BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

700 related articles for article (PubMed ID: 32460004)

  • 1. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
    Yan W; Jiang S
    Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of exosomes with lymph nodes.
    Hood JL
    Semin Cell Dev Biol; 2017 Jul; 67():29-38. PubMed ID: 27916565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
    Fanini F; Fabbri M
    Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes Function in Tumor Immune Microenvironment.
    Huang Y; Liu K; Li Q; Yao Y; Wang Y
    Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes as mediators of immune regulation and immunotherapy in cancer.
    Kugeratski FG; Kalluri R
    FEBS J; 2021 Jan; 288(1):10-35. PubMed ID: 32910536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exosomes derived from dendritic cells].
    Amigorena S
    J Soc Biol; 2001; 195(1):25-7. PubMed ID: 11530496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen Presentation by Extracellular Vesicles from Professional Antigen-Presenting Cells.
    Lindenbergh MFS; Stoorvogel W
    Annu Rev Immunol; 2018 Apr; 36():435-459. PubMed ID: 29400984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumour-derived exosomes and their roles in cancer].
    Wang K; Tang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 35(12):1288-92. PubMed ID: 21200099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy.
    Quah B; O'Neill HC
    Cancer Biother Radiopharm; 2000 Apr; 15(2):185-94. PubMed ID: 10803324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal Stem Cell: A Friend or Foe in Anti-Tumor Immunity.
    Harrell CR; Volarevic A; Djonov VG; Jovicic N; Volarevic V
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential of exosomes in immunotherapy.
    Chaput N; Taïeb J; André F; Zitvogel L
    Expert Opin Biol Ther; 2005 Jun; 5(6):737-47. PubMed ID: 15952905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruiting T cells in cancer immunotherapy.
    Yost KE; Chang HY; Satpathy AT
    Science; 2021 Apr; 372(6538):130-131. PubMed ID: 33833111
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression.
    Czernek L; Düchler M
    Arch Immunol Ther Exp (Warsz); 2017 Aug; 65(4):311-323. PubMed ID: 28101591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cell biology and its role in tumor immunotherapy.
    Wang Y; Xiang Y; Xin VW; Wang XW; Peng XC; Liu XQ; Wang D; Li N; Cheng JT; Lyv YN; Cui SZ; Ma Z; Zhang Q; Xin HW
    J Hematol Oncol; 2020 Aug; 13(1):107. PubMed ID: 32746880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the exosome-induced immune response for cancer immunotherapy.
    Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
    Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling putative therapeutic implications of exosome exchange between tumor and immune cells.
    Lu M; Huang B; Hanash SM; Onuchic JN; Ben-Jacob E
    Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4165-74. PubMed ID: 25246552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.